Skip to content

TuHURA Biosciences, Inc. HURA Other current assets

Other current assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.6B-16.9%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s other current assets?
TuHURA Biosciences, Inc. (HURA) reported other current assets of $684.16K in Q1 2026.
How has TuHURA Biosciences, Inc.'s other current assets changed year-over-year?
TuHURA Biosciences, Inc.'s other current assets decreased by 31.8% year-over-year, from $1M to $684.16K.
What is the long-term trend for TuHURA Biosciences, Inc.'s other current assets?
Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s other current assets has grown at a 0.7% compound annual growth rate (CAGR), from $493.77K to $501.19K.